Clinical and mental health characteristics among patients receiving medications for opioid use disorder treatment versus patients receiving low- and high-dose opioids when referred for pain management - Takeaways - MDSpire

Clinical and mental health characteristics among patients receiving medications for opioid use disorder treatment versus patients receiving low- and high-dose opioids when referred for pain management

  • By

  • Jie Yang

  • Melita Giummarra

  • Louisa Picco

  • Carolyn Arnold

  • Suzanne Nielsen

  • February 12, 2025

  • 0 min

Share

  • 1

    The study analyzed demographic and clinical characteristics of patients on opioid agonist treatment versus those on low- and high-dose opioids.

  • 2

    Among 42,182 participants, opioid agonist treatment patients had more severe mental health symptoms and longer pain duration than those on low-dose opioids.

  • 3

    Patients on opioid agonist treatment reported lower pain intensity but higher rates of multimorbidity and severe anxiety compared to high-dose opioid users.

  • 4

    The findings emphasize the need for tailored multidisciplinary pain management and mental health treatment for patients on opioid agonist therapy.

  • 5

    The study highlights a gap in research regarding the unique clinical needs of patients receiving opioid agonist treatment in pain management settings.

Original Source(s)

Clinical and mental health characteristics among patients receiving medications for opioid use disorder treatment versus patients receiving low- and high-dose opioids when referred for pain management

  • by Jie Yang, Melita Giummarra, Louisa Picco, Carolyn Arnold, Suzanne Nielsen

  • February 12, 2025

Related Content

Internalizing and externalizing pathways to internet gaming disorder: the roles of anger and social anxiety

A Self-Guided App-Based Mindfulness Intervention for Racially and Ethnically Minoritized Individuals Who Experience Discrimination-Related Mental Health Symptoms: Randomized Controlled Trial

Differential roles of dopamine D1 and D2 receptors in pain modulation: a review